Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements

The combination of dabrafenib and trametinib is a well-established treatment for BRAF-mutated melanoma. However, the effectiveness of this approach may be hindered by the development of treatment-related pyrexia syndrome, which occurs in at least 50% of treated patients. Without appropriate interven...

Descripción completa

Detalles Bibliográficos
Autores principales: Thawer, Alia, Miller, Wilson H., Gregorio, Nancy, Claveau, Joël, Rajagopal, Sudha, Savage, Kerry J., Song, Xinni, Petrella, Teresa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482100/
https://www.ncbi.nlm.nih.gov/pubmed/34590600
http://dx.doi.org/10.3390/curroncol28050304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482100/
https://www.ncbi.nlm.nih.gov/pubmed/34590600
http://dx.doi.org/10.3390/curroncol28050304

Ejemplares similares